Central Trust CO Alkermes Plc. Transaction History
Central Trust CO
- $4.19 Billion
- Q3 2024
A detailed history of Central Trust CO transactions in Alkermes Plc. stock. As of the latest transaction made, Central Trust CO holds 98 shares of ALKS stock, worth $2,796. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98
Previous 98
-0.0%
Holding current value
$2,796
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
363Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$831 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$541 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$371 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$361 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$262 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.69B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...